National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

denileukin diftitox (DEN-ih-LOO-kin DIF-tih-tox)

 A substance used to treat cutaneous T-cell lymphoma when other treatments have not worked. It is also being studied in the treatment of chronic lymphocytic leukemia that has not responded to treatment. It belongs to the family of drugs called biological therapy agents. Also called Ontak.



Previous Definitions:dementia, Demerol, dendritic cell, dendritic cell vaccine, denial
Next Definitions:denomination, denosumab, dental implant, dentist, Denys-Drash syndrome

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov